A Population‐Based Study of Children with Standard Risk Acute Lymphoblastic Leukemia in the Five Nordic Countries
- 21 January 1989
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 78 (1) , 104-109
- https://doi.org/10.1111/j.1651-2227.1989.tb10895.x
Abstract
Two hundred and thirty children with standard risk acute lymphoblastic leukemia (ALL) were diagnosed during a period of 3 years from July 1, 1981 to June 30, 1984 in the five Nordic countries. Criteria for standard risk ALL were age above 2.0 and below 10 years, WBC .ltoreq.20 .times. 109/l, no evidence of CNS-involvement, mediastinal mass or T- or B-cell leukemia. The children were treated without prophylactic CNS irradiation, the majority (200 patients) according to two treatment programs. Follow-up of the entire group after a minimum of 30 months showed 64% of the children living in complete continuous remission with a probability of event-free survival of 0.60. The treatment results are not entirely satisfactory and intensification of therapy is required. A subgroup of patients with WBC between 10 and 20 .times. 109/l and with adverse prognosis was identified, justifying a change of the present criteria for risk grouping.Keywords
This publication has 8 references indexed in Scilit:
- A Population‐Based Study of Childhood Acute Lymphoblastic Leukemia Diagnosed from July 1981 through June 1985 in the Five Nordic CountriesActa Paediatrica, 1987
- Die Behandlung der akuten lymphoblastischen Leukämie im Kindes- und Jugendalter: Ergebnisse der multizentrischen Therapiestudie ALL-BFM 81*Klinische Padiatrie, 1987
- Methotrexate infusions in poor prognosis acute lymphoblastic leukemia in children: I. The Norwegian methotrexate study in acute lymphoblastic leukemia in childhood, august 1975‐December 1980Medical and Pediatric Oncology, 1986
- High risk acute lymphoblastic leukemia in DenmarkEuropean Paediatric Haematology and Oncology, 1984
- Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group studyBlood, 1982
- EQUIVALENCE OF INTRATHECAL CHEMOTHERAPY AND RADIOTHERAPY AS CENTRAL NERVOUS-SYSTEM PROPHYLAXIS IN CHILDREN WITH ACUTE LYMPHATIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY1982
- INTERMEDIATE DOSE METHOTREXATE (IDM) IN CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA IN NORWAYActa Paediatrica, 1981
- Evaluation of dose and schedule of L‐asparaginase in multidrug therapy of childhood leukemiaMedical and Pediatric Oncology, 1976